Guardant Health Share Price (NASDAQ: GH)

$57.67

▲

-0.9

(-1.54%)

Live

Last updated on August 20, 2025 at 11:41 PM IST

$₹

Check the interactive Guardant Health Stock chart to analyse performance

Guardant Health stock performance

as on August 20, 2025 at 11:41 PM IST

Today's Low:$57.64
Today's High:$58.55
$57.67
0.05%
Downside
Day's Volatility :1.55%
Upside
1.5%
52 Weeks Low:$20.14
52 Weeks High:$60.68
$57.67
65.08%
Downside
52 Weeks Volatility :66.81%
Upside
4.96%

Guardant Health Stock Returns

Period	Guardant Health, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	57.9%	1.5%	0.0%
6 Months	19.52%	-7.1%	0.0%
1 Year	111.58%	-11.4%	0.0%
3 Years	24.24%	2.9%	-9.6%

Guardant Health, Inc. Key Stats

Check Guardant Health key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$58.57
Open	$58.73
Today's High	$58.55
Today's Low	$57.64
Market Capitalization	$7.4B
Today's Volume	$2.5M
52 Week High	$60.68
52 Week Low	$20.14
Revenue TTM	$828.8M
EBITDA	$-419.1M
Earnings Per Share (EPS)	$-3.35
Profit Margin	-49.93%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4584.47%

Stock Returns calculator for Guardant Health Stock including INR - Dollar returns

The Guardant Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Guardant Health investment value today

Current value as on today

₹2,12,234

Returns

₹1,12,234

(+112.23%)

Returns from Guardant Health Stock

₹1,08,345 (+108.35%)

Dollar Returns*

₹3,889 (+3.89%)

Indian investors sentiment towards Guardant Health Stock

-11%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Guardant Health Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Guardant Health, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
9.76%
BlackRock Inc
8.96%
Capital Research & Mgmt Co - Division 3
3.99%
Baillie Gifford & Co Limited.
3.86%
Cadian Capital Management LP
3.68%
Deep Track Capital, LP
3.41%

Analyst Recommendation on Guardant Health Stock

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 30 Wall street analysts offering stock ratings for Guardant Health(by analysts ranked 0 to 5 stars)

Guardant Health Share Price Target

What analysts predicted

Upside of 6.35%

Target:

$61.33

Current:

$57.67

Guardant Health share price target is $61.33, a slight Upside of 6.35% compared to current price of $57.67 as per analysts' prediction.

Guardant Health Stock Insights

Price Movement
In the last 1 month, GH stock has moved up by 26.1%
Increasing Revenue
Revenue is up for the last 14 quarters, 96.09M → 232.08M (in $), with an average increase of 6.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -95.15M → -99.89M (in $), with an average decrease of 5.0% per quarter
GH vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 70.3% return, outperforming this stock by 47.7%

Guardant Health, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$214.4M	↑ 136.52%
Net Income	$-75.7M	↓ 11.06%
Net Profit Margin	-35.29%	↑ 58.56%

	FY20	Y/Y Change
Revenue	$286.7M	↑ 33.75%
Net Income	$-253.8M	↑ 235.47%
Net Profit Margin	-88.51%	↓ 53.22%

	FY21	Y/Y Change
Revenue	$373.7M	↑ 30.32%
Net Income	$-405.7M	↑ 59.85%
Net Profit Margin	-108.57%	↓ 20.06%

	FY22	Y/Y Change
Revenue	$449.5M	↑ 20.31%
Net Income	$-654.6M	↑ 61.36%
Net Profit Margin	-145.61%	↓ 37.04%

	FY23	Y/Y Change
Revenue	$563.9M	↑ 25.45%
Net Income	$-479.4M	↓ 26.76%
Net Profit Margin	-85.02%	↑ 60.59%

	FY24	Y/Y Change
Revenue	$739.0M	↑ 31.04%
Net Income	$-436.4M	↓ 8.98%
Net Profit Margin	-59.05%	↑ 25.97%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$168.5M	↑ 8.67%
Net Income	$-115.0M	↓ 38.52%
Net Profit Margin	-68.24%	↑ 52.39%

	Q2 FY24	Q/Q Change
Revenue	$177.2M	↑ 5.19%
Net Income	$-102.6M	↓ 10.75%
Net Profit Margin	-57.91%	↑ 10.33%

	Q3 FY24	Q/Q Change
Revenue	$191.5M	↑ 8.04%
Net Income	$-107.8M	↑ 4.99%
Net Profit Margin	-56.28%	↑ 1.63%

	Q4 FY24	Q/Q Change
Revenue	$201.8M	↑ 5.4%
Net Income	$-111.0M	↑ 3.02%
Net Profit Margin	-55.0%	↑ 1.28%

	Q1 FY25	Q/Q Change
Revenue	$203.5M	↑ 0.82%
Net Income	$-95.2M	↓ 14.28%
Net Profit Margin	-46.77%	↑ 8.23%

	Q2 FY25	Q/Q Change
Revenue	$232.1M	↑ 14.06%
Net Income	$-99.9M	↑ 4.98%
Net Profit Margin	-43.04%	↑ 3.73%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$143.7M	↑ 202.88%

	FY20	Y/Y Change
Profit	$194.2M	↑ 35.18%

	FY21	Y/Y Change
Profit	$250.7M	↑ 29.12%

	FY22	Y/Y Change
Profit	$293.2M	↑ 16.94%

	FY23	Y/Y Change
Profit	$336.9M	↑ 14.9%

	FY24	Y/Y Change
Profit	$449.2M	↑ 33.34%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$103.2M	↓ 56.31%

	Q2 FY24	Q/Q Change
Profit	$104.8M	↑ 1.57%

	Q3 FY24	Q/Q Change
Profit	$117.0M	↑ 11.61%

	Q4 FY24	Q/Q Change
Profit	$124.2M	↑ 6.18%

	Q1 FY25	Q/Q Change
Profit	$128.7M	↑ 3.64%

	Q2 FY25	Q/Q Change
Profit	$150.9M	↑ 17.19%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-47.1M	↓ 34.7%
Investing Cash Flow	$-317.6M	↑ 107.52%
Financing Cash Flow	$367.3M	↑ 25.29%

	FY20	Y/Y Change
Operating Cash Flow	$-103.9M	↑ 120.49%
Investing Cash Flow	$-617.1M	↑ 94.31%
Financing Cash Flow	$1.4B	↑ 283.96%

	FY21	Y/Y Change
Operating Cash Flow	$-209.0M	↑ 101.12%
Investing Cash Flow	$-63.2M	↓ 89.77%
Financing Cash Flow	$-66.8M	↓ 104.74%

	FY22	Y/Y Change
Operating Cash Flow	$-309.5M	↑ 48.06%
Investing Cash Flow	$149.8M	↓ 337.22%
Financing Cash Flow	$-189.1M	↑ 182.97%

	FY23	Y/Y Change
Operating Cash Flow	$-325.0M	↑ 5.01%
Investing Cash Flow	$840.3M	↑ 460.85%
Financing Cash Flow	$477.4M	↓ 352.46%

	FY24	Y/Y Change
Operating Cash Flow	$-239.9M	↓ 26.19%
Investing Cash Flow	$-261.3M	↓ 131.1%
Financing Cash Flow	$-996.0K	↓ 100.21%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-30.3M	↓ 61.53%
Investing Cash Flow	$28.1M	↓ 95.77%
Financing Cash Flow	$-1.1M	↓ 101.19%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-94.0M	↑ 210.4%
Investing Cash Flow	$-5.1M	↓ 118.09%
Financing Cash Flow	$5.9M	↓ 649.16%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-51.1M	↓ 45.68%
Investing Cash Flow	$-294.8M	↑ 5707.11%
Financing Cash Flow	$-2.9M	↓ 148.91%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-64.5M	↑ 26.35%
Investing Cash Flow	$10.5M	↓ 103.57%
Financing Cash Flow	$-2.9M	↑ 1.73%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-62.7M	↓ 2.83%
Investing Cash Flow	$302.9M	↑ 2776.2%
Financing Cash Flow	$-66.9M	↑ 2177.68%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-60.3M	↓ 3.83%
Investing Cash Flow	$-10.6M	↓ 103.52%
Financing Cash Flow	$1.6M	↓ 102.43%

Guardant Health Technicals Summary

Sell

Neutral

Buy

Guardant Health is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Guardant Health, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Guardant Health, Inc.	28.32%	19.52%	111.58%	24.24%	-37.35%
Agilent Technologies Inc.	7.23%	-12.4%	-14.03%	-10.3%	22.22%
Idexx Laboratories, Inc.	22.21%	41.15%	28.86%	77.61%	66.0%
Thermo Fisher Scientific, Inc.	23.09%	-6.1%	-18.89%	-13.48%	16.31%
Danaher Corp.	12.84%	3.53%	-21.88%	-25.79%	2.13%
Iqvia Holdings Inc.	21.04%	-2.09%	-22.08%	-16.91%	22.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Guardant Health, Inc.	NA	NA	NA	-1.88	-45.84	-0.2	NA	-2.45
Agilent Technologies Inc.	29.58	29.58	1.74	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	52.98	52.98	4.77	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.17	28.17	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	44.47	44.47	2.09	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.92	27.92	1.1	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Guardant Health, Inc.	Buy	$7.4B	-37.35%	NA	-49.93%
Agilent Technologies Inc.	Buy	$34.1B	22.22%	29.58	17.59%
Idexx Laboratories, Inc.	Buy	$51.0B	66.0%	52.98	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.1B	16.31%	28.17	15.24%
Danaher Corp.	Buy	$149.7B	2.13%	44.47	14.21%
Iqvia Holdings Inc.	Buy	$32.7B	22.11%	27.92	7.88%

Guardant Health Dividend announcements

Guardant Health Earnings
Guardant Health’s price-to-earnings ratio stands at None

About Guardant Health, Inc.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Organization	Guardant Health
Employees	1999
CEO	Dr. AmirAli Talasaz Ph.D.
Industry	Health Services

Key Management of Guardant Health, Inc.

Name	Title
Dr. Helmy Eltoukhy Ph.D.	Co-Founder, Co-CEO & Chairman
Dr. AmirAli Talasaz Ph.D.	Co-CEO & Director
Mr. Michael Bell	Chief Financial Officer
Ms. Darya Chudova	Chief Technology Officer
Mr. John G. Saia J.D.	Chief Legal Officer & Corporate Secretary
Ms. Terilyn Juarez Monroe	Chief People Officer
Mr. Andy Ament	Senior Vice President of Operations
Mr. Kumud Kalia	Chief Information Officer
Zarak Khurshid	Vice President of Investor Relations
Ms. Gulshan Shaver J.D.	Senior VP of Legal Affairs & Chief Compliance Officer

Important FAQs about investing in GH Stock from India :

What is Guardant Health share price today?

Guardant Health share price today is $57.67 as on August 20, 2025 at 11:41 PM IST. Guardant Health share today touched a day high of $58.55 and a low of $57.64.

What is the 52 week high and 52 week low for Guardant Health share?

Guardant Health share touched a 52 week high of $60.68 and a 52 week low of $20.14. Guardant Health stock price today i.e. August 20, 2025 at 11:41 PM IST is trending at $57.67, lower by 4.96% versus the 52 week high.

How to invest in Guardant Health Stock (GH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Guardant Health on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Guardant Health Shares that will get you 0.0260 shares as per Guardant Health share price of $57.67 per share as on August 20, 2025 at 11:41 PM IST.

What is the minimum amount required to buy Guardant Health Stock (GH) from India?

Indian investors can start investing in Guardant Health (GH) shares with as little as ₹87.0225 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹870.22 in Guardant Health stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Guardant Health share’s latest price of $57.67 as on August 20, 2025 at 11:41 PM IST, you will get 0.1734 shares of Guardant Health. Learn more about fractional shares .

What are the returns that Guardant Health has given to Indian investors in the last 5 years?

Guardant Health stock has given -37.35% share price returns and 16.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?